- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge Technologies makes management move
Merge Technologies makes management moveConnectivity and PACS firm Merge Technologies has named Joseph Gentile director of worldwide system sales. Gentile will manage the Milwaukee, WI, firm’s systems solution group, which provides medical
Merge Technologies makes management move
Connectivity and PACS firm Merge Technologies has named Joseph Gentile director of worldwide system sales. Gentile will manage the Milwaukee, WI, firms systems solution group, which provides medical connectivity products and medical information appliances and servers. The company expects Gentiles experience as vice president of sales of IMACS Medical, which created a networked data and information management system for cardiology, to help it boost its business.
In other Merge news, the company last month began shipping its second-generation medical image information server MergeARK to facilities in Europe. MergeARK is part of the firms MergeWorks suite of products, and has been upgraded to improve its storage, retrieval, and reprint capacities. MergeARKs hardware and operating system software are now based on Dell servers and Red Hat Linux version 6.0, respectively. Some of Merges European installations of MergeARK will include DRM-7000, a CD-R library from Pioneer that can store 670 CDs to provide data storage of more than 400 gigabytes.
© 2000 Miller Freeman, Inc., a United News & Media company
- Search again
- Homepage
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
